Soenen R - Search Results

1

Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis.

Van den Berghe N, De Keyser E, Soenen R, Meuleman L, Lanssens S, Gils A, Lambert J. Van den Berghe N, et al. Among authors: soenen r. Br J Dermatol. 2020 Feb;182(2):390-397. doi: 10.1111/bjd.18016. Epub 2019 Jul 24. Br J Dermatol. 2020. PMID: 31004510 Free PMC article.

2

Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy.

Soenen R, Meulewaeter E, Grine L, Van den Berghe N, Brouwers E, Speeckaert R, Lanssens S, Temmerman L, Lambert J, Gils A. Soenen R, et al. J Invest Dermatol. 2019 Oct;139(10):2232-2235.e1. doi: 10.1016/j.jid.2019.04.012. Epub 2019 May 5. J Invest Dermatol. 2019. PMID: 31067484 Free article. Clinical Trial. No abstract available.

3

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis.

Van den Berghe N, Truffot A, Peeters M, Compernolle G, Brouwers E, Soenen R, Grine L, Gils A, Imbrechts M. Van den Berghe N, et al. Among authors: soenen r. J Pharm Biomed Anal. 2020 Sep 10;189:113433. doi: 10.1016/j.jpba.2020.113433. Epub 2020 Jun 18. J Pharm Biomed Anal. 2020. PMID: 32615342

4

Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey.

Schots L, Grine L, Soenen R, Lambert J. Schots L, et al. Among authors: soenen r. J Dermatolog Treat. 2022 May;33(3):1473-1481. doi: 10.1080/09546634.2020.1832649. Epub 2020 Oct 15. J Dermatolog Treat. 2022. PMID: 33019835 Free article.

5

Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.

Soenen R, Wang Z, Grine L, Dreesen E, Schots L, Brouwers E, Declerck P, Thomas D, Lambert J. Soenen R, et al. Clin Exp Dermatol. 2022 Jul;47(7):1324-1336. doi: 10.1111/ced.15157. Epub 2022 Apr 25. Clin Exp Dermatol. 2022. PMID: 35245966 Free PMC article.

6

Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study.

Benhadou F, Ghislain PD, Guiot F, Willaert F, Del Marmol V, Lambert J, Soenen R, Fierens H, de la Brassinne M. Benhadou F, et al. Among authors: soenen r. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e837-e839. doi: 10.1111/jdv.16715. Epub 2020 Jun 26. J Eur Acad Dermatol Venereol. 2020. PMID: 32535976 No abstract available.

7

Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice.

Soenen R, Stove C, Capobianco A, De Schutter H, Dobbelaere M, Mahjor T, Follens M, Lambert J, Grine L. Soenen R, et al. J Clin Med. 2022 May 26;11(11):3011. doi: 10.3390/jcm11113011. J Clin Med. 2022. PMID: 35683398 Free PMC article.

8

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.

Ghislain PD, Failla V, Lambert J, Soenen R, Grine L, Tannous J, Guiot F, Willaert F, Fierens H, Vandaele M, Boonen H, Saerens J, Meuleman V, Stockman A, Belpaire A, Swimberghe S, Temmerman L, Dekeyser S, Lambert JM, de Schaetzen V, de la Brassinne M, Benhadou F. Ghislain PD, et al. Among authors: soenen r. JAAD Int. 2021 Jun 1;4:15-17. doi: 10.1016/j.jdin.2021.05.001. eCollection 2021 Sep. JAAD Int. 2021. PMID: 34409384 Free PMC article. No abstract available.

9

Creasensor: SIMPLE technology for creatinine detection in plasma.

Dal Dosso F, Decrop D, Pérez-Ruiz E, Daems D, Agten H, Al-Ghezi O, Bollen O, Breukers J, De Rop F, Katsafadou M, Lepoudre J, Lyu L, Piron P, Saesen R, Sels S, Soenen R, Staljanssens E, Taraporewalla J, Kokalj T, Spasic D, Lammertyn J. Dal Dosso F, et al. Among authors: soenen r. Anal Chim Acta. 2018 Feb 13;1000:191-198. doi: 10.1016/j.aca.2017.11.026. Epub 2017 Nov 22. Anal Chim Acta. 2018. PMID: 29289308

10

Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021.

Meulewaeter E, Eylenbosch A, Verhaeghe E, Soenen R, Lambert J. Meulewaeter E, et al. Among authors: soenen r. Dermatol Ther (Heidelb). 2024 Oct;14(10):2889-2903. doi: 10.1007/s13555-024-01277-y. Epub 2024 Oct 4. Dermatol Ther (Heidelb). 2024. PMID: 39365432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters